Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

UK Launches Rapid Response Funding for Zika Research

by Global Biodefense Staff
February 8, 2016

The UK Medical Research Council (MRC) has announced a ‘Rapid Response’ call for research applications aimed at tackling the risk posed by the Zika virus.

‘Rapid Responses’ aim to accelerate the speed at which essential funding can be allocated in emergency situations. Under circumstances of emerging threats with serious and immediate risk to human health, applications for funding are directly assessed by a scientific panel and are not subject to usual peer review. All proposals must be clear in why the funding is needed now and cannot wait until the next round of core funding.

Initially, up to £1 million from the UK Government’s Global Challenges Research Fund will be made available through the Rapid Response mechanism to researchers applying for grants to investigate the nature of the virus, its transmission and the potential links to neurological conditions including microcephaly.

Possible avenues of research to be funded by this initiative could include:

  • Epidemiological characteristics, e.g. vector transmission potential, geographical spread, interactions with other arboviruses, changing viral genotype, host susceptibility, incubation period, etc.
  • Development of more specific rapid diagnostic tests for Zika virus that can reduce misdiagnosis that may occur due to the presence of dengue or other viruses in a test sample
  • Viral pathogenicity, association with and potential mechanistic links to neurodevelopment / microcephaly
  • Mechanisms of infection and host immune responses and potential therapeutics.

“It’s critical that we find out more about the Zika virus as soon as possible, so we are allocating funding to help researchers answer some of the most pressing questions about the disease,” said Professor Sir John Savill, the MRC’s chief. “We need to be able to develop treatments and vaccines but first we need answers to vital questions about the nature of this virus –  such as if and how it is changing, how to control the spread of the disease, and how to both diagnose and prevent infection.”

At the same time as the rapid response initiative, the UK MRC and the Foundation for Science and Technology of the state of Pernambuco (FACEPE) have recently agreed to jointly fund a research proposal to investigate the viral features and host responses to Zika virus with a view to designing new preventative strategies. This agreement follows a joint call for research applications under the UK Government’s Newton Fund.

Researchers at the UK MRC Centre for Virus Research at the University of Glasgow will be working with a team at the Research Center Aggeu Magalhães at the Oswaldo Cruz Foundation, Pernambuco, Brazil.

The joint award is around £300,000 in total.

The main objective of the project is to study the presence and epidemiology of the Zika virus in Brazil and to understand how the immune system of people infected with the virus responds to the infection. Genetic techniques will be used to support diagnostics and vaccine development studies as well as helping to understand the biology of the Zika virus during infection.

Tags: Emerging ThreatsRequest for ProposalsVaccinesZika

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Bat Virus Receptor Studies Vital to Predict Spillover Risk
Pathogens

Bat Virus Receptor Studies Vital to Predict Spillover Risk

December 7, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC